ProShare Advisors’s Axogen AXGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$318K Sell
6,893
-106
-2% -$4.27K ﹤0.01% 1375
2026
Q1
$232K Sell
6,999
-1,124
-14% -$36.5K ﹤0.01% 1484
2025
Q4
$266K Buy
+8,123
New +$200K ﹤0.01% 1535
2025
Q1
Sell
-11,942
Closed -$197K 2101
2024
Q4
$197K Buy
+11,942
New +$169K ﹤0.01% 1892
2021
Q3
Sell
-9,895
Closed -$214K 2028
2021
Q2
$214K Sell
9,895
-79
-0.8% -$1.6K ﹤0.01% 2109
2021
Q1
$202K Buy
+9,974
New +$197K ﹤0.01% 2038
2018
Q3
Sell
-4,390
Closed -$221K 1769
2018
Q2
$221K Buy
+4,390
New +$193K ﹤0.01% 1556

Other funds holding AXGN

ProShare Advisors's AXGN Position: Q2 2026 in Review

ProShare Advisors reduced its Axogen (AXGN) stake by 1.5% in Q2 2026, selling an estimated $4.27K and leaving 6,893 shares worth $318K. The position accounts for ﹤0.01% of the portfolio, ranked #1375.

ProShare Advisors first reported a position in AXGN in Q2 2018 and has held it in 7 quarters since. 253 funds tracked by Wall St. Rank hold AXGN as of Q2 2026.

  • ProShare Advisors held 6,893 shares of Axogen worth $318K as of Q2 2026.
  • ProShare Advisors sold 106 Axogen shares in Q2 2026, an estimated $4.27K.
  • Axogen made up ﹤0.01% of ProShare Advisors's portfolio in Q2 2026, its #1375 holding.
  • ProShare Advisors first reported a position in Axogen in Q2 2018 and has held it in 7 quarters since.
  • 253 funds tracked by Wall St. Rank held Axogen as of Q2 2026.

Based on ProShare Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.